JSETRI
DEAD

Serial Number

79236503

Owner

NOVARTIS AG

Filing Date

May 2, 2018

Add to watchlist:

No watchlists yet
View on USPTO

JSETRI Trademark

Serial Number: 79236503 • Registration: 5609270

JSETRI is a trademark filed by NOVARTIS AG on May 2, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,135 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

May 2, 2018

Registration Date

November 20, 2018

Published for Opposition

September 4, 2018

Cancellation Date

October 2, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

DEATH OF INTERNATIONAL REGISTRATION
Jun 12, 2025 DETH
NOTIFICATION PROCESSED BY IB
Sep 25, 2022 GPNX
NOTIFICATION PROCESSED BY IB
May 23, 2022 GPNX
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Feb 20, 2022 DENC
DEATH OF INTERNATIONAL REGISTRATION
Feb 20, 2022 DETH
NOTIFICATION PROCESSED BY IB
Mar 1, 2019 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jan 2, 2019 FICS
FINAL DISPOSITION PROCESSED
Jan 2, 2019 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Dec 20, 2018 GPAR
REGISTERED-PRINCIPAL REGISTER
Nov 20, 2018 R.PR
PUBLISHED FOR OPPOSITION
Sep 4, 2018 PUBO
NOTICE OF PUBLICATION
Aug 15, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 27, 2018 CNSA
ASSIGNED TO EXAMINER
Jul 27, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 24, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 18, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 16, 2018 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jul 12, 2018 SDRC